Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre.
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Warning letters1
Philips North America — Warning letters0
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Recalls0
Philips North America — Recalls355
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Approval records0
Philips North America — Approval records0
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre — Form 483s0
Philips North America — Form 483s0
Timeline
Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
Most recent FDA action: April 29, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 28, 2026. https://argushq.ai/compare/mukesh-b-chandre-m-d-mbbs-ashirwad-hospital-and-research-centre-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗